Strattera vs. Ritalin: What Is the Difference? Strattera and Ritalin are medicines that children and adults can take to manage symptoms of attention deficit hyperactivity disorder (ADHD). Both drugs ...

Eli Lilly and Company announced today that it has added a warning to Strattera (search), an attention deficit hyperactivity disorder (ADHD) medication. Lilly says Strattera should be stopped in ...

Simply sign up to the US & Canadian companies myFT Digest -- delivered directly to your inbox. Eli Lilly warned on Thursday that its attention deficit disorder drug Strattera increased risk of ...

A not yet released discussion paper written by the British Medicines and Healthcare Regulatory Agency, reveals that last fall, there were 130 reports of suicidality in a single month by patients ...

The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit ...

One of the main benefits touted by Lilly is that Strattera is the only ADHD drug on the market that is not a stimulant, meaning users are less likely to abuse it. The makers of Adderall and Concerta ...

Dec. 20, 2004 — The U.S. Food and Drug Administration (FDA) has warned healthcare professionals via a talk paper of changes to the safety labeling for atomoxetine (Strattera, made by Eli Lilly), ...

The Food and Drug Administration (FDA) is advising health care professionals about a new warning for Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and ...

Sept. 29, 2005 — The U.S. Food and Drug Administration (FDA) has warned healthcare professionals regarding an increased risk of suicidal thinking in children and adolescents treated with atomoxetine ...

Strattera 80 mg are not intended to have pharmacological activity; nevertheless adverse reactions are possible. Adverse reactions to iodine contrast agents are related to iodine concentration, ...

Eli Lilly and Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention deficit hyperactivity drug Strattera. The U.S. District Court for the District ...

An Australian researcher wrongly told a university ethics committee that Eli Lilly's Strattera did not have a black box warning label in an application for a trial of the drug in children. At the same ...